These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8592994)

  • 1. Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.
    Coudron PE; Stratton CW
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2641-4. PubMed ID: 8592994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
    Coudron PE; Stratton CW
    J Antimicrob Chemother; 1998 Nov; 42(5):657-60. PubMed ID: 9848452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
    Ling TK; Cheng AF; Sung JJ; Yiu PY; Chung SS
    Helicobacter; 1996 Mar; 1(1):57-61. PubMed ID: 9398914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.
    Pendland SL; Prause JL; Neuhauser MM; Boyea N; Hackleman JM; Danziger LH
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2518-20. PubMed ID: 10952605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
    Boyanova L; Stancheva I; Spassova Z; Katzarov N; Mitov I; Koumanova R
    J Med Microbiol; 2000 May; 49(5):415-418. PubMed ID: 10798553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
    López-Brea M; Domingo D; Sánchez I; Prieto N; Alarcón T
    J Antimicrob Chemother; 1998 Sep; 42(3):309-14. PubMed ID: 9786470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
    González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
    Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.
    Midolo PD; Lambert JR; Turnidge J
    J Gastroenterol Hepatol; 1996 Mar; 11(3):290-2. PubMed ID: 8742929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metronidazole resistance on the eradication of Helicobacter pylori.
    Noach LA; Langenberg WL; Bertola MA; Dankert J; Tytgat GN
    Scand J Infect Dis; 1994; 26(3):321-7. PubMed ID: 7939433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.
    Pavicić MJ; Namavar F; Verboom T; van Winkelhoff AJ; De Graaff J
    Antimicrob Agents Chemother; 1993 May; 37(5):1184-6. PubMed ID: 8517712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
    Graham DY; Saeed MA; Hoffman J; El-Zimaity HM; Kwon DH; Osato MS
    Aliment Pharmacol Ther; 2001 Apr; 15(4):513-8. PubMed ID: 11284780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
    Liang X; Xu X; Zheng Q; Zhang W; Sun Q; Liu W; Xiao S; Lu H
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):802-7.e1. PubMed ID: 23376004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bactericidal activity of carbon monoxide-releasing molecules against Helicobacter pylori.
    Tavares AF; Parente MR; Justino MC; Oleastro M; Nobre LS; Saraiva LM
    PLoS One; 2013; 8(12):e83157. PubMed ID: 24386154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
    Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
    Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.
    Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J
    J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.
    Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B
    Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate.
    Andersen LP; Colding H; Kristiansen JE
    Int J Antimicrob Agents; 2000 Apr; 14(3):231-4. PubMed ID: 10773493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia.
    Al-Qurashi AR; El-Morsy F; Al-Quorain AA
    Int J Antimicrob Agents; 2001 Mar; 17(3):233-6. PubMed ID: 11282271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.